| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T786 |
0-89 |
Sentence |
denotes |
CPMS Registration Number Registration Date Clinical research unit Registration title |
| T787 |
90-283 |
Sentence |
denotes |
XYPJ ChiCTR2000029756 2020/2/12 Renmin Hospital of Wuhan University (Wuhan, China) Clinical study of nebulized Xiyanping injection in the treatment of novel coronavirus pneumonia (COVID-19) |
| T788 |
284-576 |
Sentence |
denotes |
ChiCTR2000030117 2020/2/23 Jiangxi Qingfeng Pharmaceutical Co., Ltd. (Ganzhou, China) A multicenter, randomized, open, parallel controlled trial for the evaluation of the effectiveness and safety of Xiyanping injection in the treatment of common type novel coronavirus pneumonia (COVID-19) |
| T789 |
577-706 |
Sentence |
denotes |
ChiCTR2000030218 2020/2/25 Fifth People’s Hospital of Ganzhou (Ganzhou, China) Study of Pinavir/Ritonavir tablets (Trade Name: |
| T790 |
707-792 |
Sentence |
denotes |
Kelizhi) Combined with Xiyanping injection for novel coronavirus pneumonia (COVID-19) |
| T791 |
793-1080 |
Sentence |
denotes |
LHQWC ChiCTR2000029433 2020/2/1 Hebei Yiling Hospital (Shijiazhuang, China), Renmin Hospital of Wuhan University (Wuhan, China) A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/granule in the treatment of suspected novel coronavirus pneumonia (COVID-19) |
| T792 |
1081-1351 |
Sentence |
denotes |
ChiCTR2000029434 2020/2/1 Hebei Yiling Hospital (Shijiazhuang, China), Renmin Hospital of Wuhan University (Wuhan, China) A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/granule in the treatment of novel coronavirus pneumonia (COVID-19) |
| T793 |
1352-1633 |
Sentence |
denotes |
TRQI ChiCTR2000029432 2020/2/1 The First Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangzhou, China) A real world study for the efficacy and safety of large dose Tanreqing injection in the treatment of patients with novel coronavirus pneumonia (COVID-19) |
| T794 |
1634-1817 |
Sentence |
denotes |
ChiCTR2000029813 2020/2/14 Shanghai Public Health Clinical Center (Shanghai, China) Clinical trial for Tanreqing capsules in the treatment of novel coronavirus pneumonia (COVID-19) |
| T795 |
1818-2051 |
Sentence |
denotes |
XBJI ChiCTR2000029381 2020/1/27 The First Affiliated Hospital of Guangzhou Medical University (Guangzhou, China) A prospective comparative study for Xue-Bi-Jing injection in the treatment of novel coronavirus pneumonia (COVID-19) |
| T796 |
2052-2251 |
Sentence |
denotes |
ChiCTR2000030388 2020/3/1 Jingzhou First People’s Hospital (Jingzhou, China) Efficacy and safety of Xue-Bi-Jing injection in the treatment of severe cases of novel coronavirus pneumonia (COVID-19) |
| T797 |
2252-2479 |
Sentence |
denotes |
SFJDC ChiCTR2000030043 2020/2/21 Peking University Third Hospital (Beijing, China) Shen-Fu injection in the treatment of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial |
